Black Agenda Report
Black Agenda Report
News, commentary and analysis from the black left.

  • Home
  • Africa
  • African America
  • Education
  • Environment
  • International
  • Media and Culture
  • Political Economy
  • Radio
  • US Politics
  • War and Empire

New Ebola Drugs Show Exciting Promise With Up To 90 Percent Cure Rate
Global Information Network
14 Aug 2019
🖨️ Print Article
New Ebola Drugs Show Exciting Promise With Up To 90 Percent Cure Rate / Photo:  Dr. Jean-Jacques Muyembe
New Ebola Drugs Show Exciting Promise With Up To 90 Percent Cure Rate

A breakthrough in the fight against one of the world’s most terrifying diseases. 

“Now we can say that 90 percent can come out of treatment cured, they will start believing it and developing trust.”

Two experimental treatments are raising hopes among medical personnel that a cure for the deadly virus Ebola has been found.

The antibody-based treatments will now be offered to all patients in the Democratic Republic of Congo.

Dr. Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases, announced the finding together with Dr. Jean-Jacques Muyembe, director of Congo’s National Institute for Biomedical Research and Dr. Michael  J. Ryan, director of emergency response for the World Health Organization.

Psychologically, Dr. Muyembe said, news of a cure could change the course of this outbreak, which is the worst of the 10 that Congo has endured.

“News of a cure could change the course of this outbreak.”

After years of war and genocide, residents of eastern Congo are deeply distrustful of the government in the capital, Kinshasa. Rumors have spread that Ebola does not exist, or that treatment teams steal blood and body parts for witchcraft. Treatment centers have been shot up or burned down.

“Now we can say that 90 percent can come out of treatment cured, they will start believing it and developing trust,” Dr. Muyembe said. “The first ones to transmit this information will be the patients themselves.”

Dr. Muyembe, 77, whom Dr. Fauci referred to as a “true hero,”has been fighting Ebola since it first appeared in what was then Zaire in 1976. (He) is a unique and courageous African health leader”, said Peter Piot, Professor of Global Health and Director of the London School of Hygiene & Tropical Medicine, who first met Muyembe at Yambuku. “He stayed in Congo during decades of very turbulent history and succeeded in maintaining scientific excellence and integrity throughout. He has trained several generations of much needed physicians, microbiologists, and public health workers in DRC. He is a role model for many of us.”

“Dr. Muyembe is a ‘true hero.’”

The epidemic, which was declared a public health emergency last month, has now infected about 2,800 known patients, killing more than 1,800 of them,according to the world health body.

The new experimental treatments, known as REGN-EB3 and mAb-114, are both cocktails of monoclonal antibodies that are infused intravenously into the blood. The drugs are most effective when used as treatments for patients with low levels of Ebola in the bloodstream, according to the peer-reviewed journal Nature.

Both drugs are U.S. made. REGN-EB3 is made by Regeneron Pharmaceuticals of Tarrytown, N.Y. Dr. Fauci’s institute, which is part of the National Institutes of Health, developed mAb114 and licensed production last year to Ridgeback Biotherapeutics, a Miami company.

The two new therapies were among four tested in a trial that has enrolled almost 700 patients since November. The two worked so well that a committee recommended that the other two treatments, ZMapp, made by Mapp Biopharmaceutical, and remdesivir, made by Gilead Sciences, be stopped. All patients will now be offered either the Regeneron or the Biotherapeutics drug.

“The epidemic has now infected about 2,800 known patients, killing more than 1,800 of them.”

Fauci paid tribute to all of those involved in the trial in four towns: Beni, Katwa, Butembo and Mangina. NGOs including International Medical Corps and Doctors Without Borders “put their lives on the line every day to care for patients in extremely difficult conditions in the area where the outbreak is occurring,” he said.

Decades ago, Dr. Muyembe pioneered the use of survivors’ blood serum — which contains antibodies — in order to save patients. The two experiment treatments that proved successful last week descend in part from his original research.

 Asked how he felt about that during a telephone news conference, Dr. Muyembe said through a translator: “I’m a little sentimental. I had this idea a long time ago, and I’ve waited patiently for it. I’m very happy, and I can’t believe it.”

The Regeneron treatment — the one with the best results — was added to the clinical trial at the last minute only after reconsideration by a WHO panel of experts, the company said.

Global Information Network, Ltd. or GIN, incorporated in 1986, is an independent, New York domestic non-profit news organization with an office in New York City that gathers and disseminates news from reporters in the field in Africa.

COMMENTS?

Please join the conversation on Black Agenda Report's Facebook page at http://facebook.com/blackagendareport

Or, you can comment by emailing us at comments@blackagendareport.com

Ebola

Do you need and appreciate Black Agenda Report articles? Please click on the DONATE icon, and help us out, if you can.


Related Stories

Gary Wilson
Ebola workers strike in Congo as the United States goes after the mines
04 November 2026
Washington signed agreements for Congo's copper and cobalt while Ebola spread across 67 health zones and medical workers went unpaid for their
Beverley Waithaka
Kenya Is Not America's Quarantine Zone
24 June 2026
The United States announced that Kenya, with the permission of a comprador government, would serve as an Ebola quarantine hub for Ame
Abayomi Azikiwe
Ebola Virus Disease Outbreak in Central and East Africa Causes Alarm
03 June 2026
Since early May, the World Health Organization and the African Centers for Disease Control and Prevention have been working to contain the spre

More Stories


  • The Real News Network
    March 7, 2017 Judge Accepts Class Action Lawsuit Against Use of Slave Labor in Private Detention Centers
    09 Mar 2017
    The Ford Report on the Real News Network Does $1 a day forced labor amount to slavery? A judge has certified a class action suit by immigrant detainees that could also bolster challenges to…
  • Glen Ford , BAR executive editor
    Corporate Media Counting Cadence to Fascism
    09 Mar 2017
    by BAR executive editor Glen Ford The ruling class/War Party/corporate media campaign for regime change in Washington has moments of pure silliness, with grown men claiming that U.S. presidents don’…
  • Margaret Kimberley , BAR editor and senior columnist
    Freedom Rider: Trump and Russia, the Perfect Lie
    08 Mar 2017
    by BAR editor and senior columnist Margaret Kimberley The latest New York Times article is proof that outgoing president Obama “was looking not for intelligence he knew didn’t exist, but anything…
  • Democrats Fight Trump, the Man, But Not His Austerity and Militarism
    08 Mar 2017
    A Black Agenda Radio commentary by BAR executive editor Glen Ford The Democrats would surely like to replace Donald Trump at the earliest opportunity. But they show no inclination to fight Trump and…
  • stacey
    Bruce A. Dixon , BAR managing editor
    Leading Black Democrats Love School Privatization Too
    08 Mar 2017
    Since voters nearly always reject privatization initiatives on the ballot Republicans and Democrats, both in the pay of charter school sugar daddies, are obliged to make it happen without them
  • Load More
Subscribe
connect with us
about us
contact us